CEACAM5 and teratoma: There is therefore a need to develop technologies to aid early detection of teratomas, and it has been suggested that a combination of biomarkers (α-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotrophin) along with an MRI, may provide a sensitive approach for identifying teratomas from hPSCs [86].